Memorial Sloan Kettering at Basking Ridge

The trials here

What the 12 trials at this site are about, from their registry records.

Conditions

• Triple-negative breast cancer3 trials
• Bladder cancer2 trials
• Hodgkin lymphoma2 trials
• Childhood cancers1 trial
• Chronic lymphocytic leukaemia1 trial
• Diffuse large B-cell lymphoma1 trial
• Liver and biliary tract cancer1 trial
• Lung cancer1 trial
• Mantle cell lymphoma1 trial
• Mesothelioma1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 27 trials
• Phase 12 trials
• Early phase 11 trial

Status

• Completed6 trials
• Active, not recruiting5 trials
• Recruiting1 trial

Lead sponsor

• Memorial Sloan Kettering Cancer Center12 trials

Running trials

• Recruiting

  A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

  NCT05419076· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Luke Pike, MD

• Active, not recruiting

  Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

  NCT03824483· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Active, not recruiting

  Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma

  NCT03179917· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Active, not recruiting

  Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy

  NCT02422498· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Active, not recruiting

  Communication Skills Intervention to Promote Transition Into Survivorship

  NCT01483664· Memorial Sloan Kettering Cancer Center· Source

• Active, not recruiting

  Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma

  NCT00715611· Phase 2· Memorial Sloan Kettering Cancer Center· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting

Closed trials

• Completed

  A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy

  NCT03542175· Phase 1· Memorial Sloan Kettering Cancer Center· Source

• Completed

  A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer

  NCT03143270· Early phase 1· Memorial Sloan Kettering Cancer Center· Source

• Completed

  Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer

  NCT02521363· Memorial Sloan Kettering Cancer Center· Source

• Completed

  Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients With Implant Reconstructions

  NCT02086578· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Completed

  Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma

  NCT01261728· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Completed

  Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy

  NCT01104350· Phase 1· Memorial Sloan Kettering Cancer Center· Source